At a glance
ClinicalIndex Comparison RecordPhase 4Completed· 200 enrolled
Drug / intervention
Gardasilbiological
Likely dose
Gardasil 0.5 mlfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Acceptability and Feasibility of a Modified HPV Vaccine Schedule in Brothel Based Female Sex Workers in Peru
Johns Hopkins Bloomberg School of Public Health·interventional·Posted Jun 22, 2009·Updated Oct 11, 2012
In Brief
A Phase 4 clinical trial evaluating Gardasil for Human Papillomavirus Infection. Completed, enrolled 200 participants across 1 site.
Detailed Summary
The primary objectives of this study are to determine the acceptance and potential for the effective use of HPV vaccine in the standard and a modified schedule in female sex workers. Secondary objectives include ascertaining the prevalence of HPV types among female sex workers by age and sexual experience.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsHuman Papillomavirus Infection
CountriesPeru
Timeline
Phase 4CompletedFinished
200920102011201220132014201520162017201820192020202120222023202420252026
First PostedJun 2009
Enrollment StartOct 2009
Primary CompletionAug 2011
TodayJul 2026
First PostedJun 22, 2009
Enrollment StartOct 1, 2009
Primary CompletionAug 1, 2011
TodayJul 2, 2026
Enrollment to primary: 1.8 yearsPosted 17.0 years ago
Interventions
Gardasilbiological
Dosage Form: 0.5 ml intramuscular injection Dosage: Gardasil 0.5ml suspension Frequency: 3 doses